While studies have highlighted the role of inflammatory markers such as CRP and IL-6 in depression, PHR offers distinct advantages by integrating two measurable and routinely assessed parameters: platelet count and HDL cholesterol (33–35). The gene discussed is IL6; the disease is depressive disorder.